Background Autosomal dominant polycystic kidney disease (ADPKD) is the leading inheritable cause of end-stage renal disease (ESRD); however, the natural course of disease progression is heterogeneous between patients.
Phil McEwan +9 more
doaj +1 more source
Cystic kidney diseases: many ways to form a cyst [PDF]
Renal cysts are a common radiological finding in both adults and children. They occur in a variety of conditions, and the clinical presentation, management, and prognosis varies widely.
Loftus, H., Ong, A.C.M.
core +1 more source
AIRP onlus partecipa al 1° Summit Europeo dedicato ai pazienti affetti da ADPKD
On Saturday the16th March 2019, AIRP participated at the 1st European ADPKD Patient Summit – a unique event designed to promote patient-centred care by providing an interactive forum for patients and experts to discuss ADPKD care, research and advocacy ...
Flavia Galletti, Franco Martini
doaj +1 more source
T1 vs. T2 weighted magnetic resonance imaging to assess total kidney volume in patients with autosomal dominant polycystic kidney disease [PDF]
Purpose: In ADPKD patients total kidney volume (TKV) measurement using MRI is performed to predict rate of disease progression. Historically T1 weighted images (T1) were used, but the methodology of T2 weighted imaging (T2) has evolved.
A. Lianne Messchendorp +9 more
core +1 more source
Test Retest Reproducibility of Organ Volume Measurements in ADPKD Using 3D Multimodality Deep Learning [PDF]
Xinzi He +14 more
openalex +1 more source
A novel PKD1 variant demonstrates a disease-modifying role in trans with a truncating PKD1 mutation in patients with Autosomal Dominant Polycystic Kidney Disease [PDF]
Autosomal Dominant Polycystic Kidney Disease (ADPKD) is the most common form of Polycystic Kidney Disease (PKD) and occurs at a frequency of 1/800 to 1/1000 affecting all ethnic groups worldwide.
Al-Mulla, Fahd +8 more
core
A Case of Renal Transcatheter Arterial Embolization with Ethanol in Autosomal Dominant Polycystic Kidney Disease for Volume Reduction [PDF]
We report herein the case of a 76-year-old woman with autosomal dominant polycystic kidney disease (ADPKD) and chronic renal failure resulting in intractable abdominal distension and anorexia.
Gobara, Hideo +5 more
core +1 more source
Safety and tolerability of sirolimus treatment in patients with autosomal dominant polycystic kidney disease [PDF]
Background. We initiated a randomized controlled clinical trial to assess the effect of sirolimus on disease progression in patients affected by autosomal dominant polycystic kidney disease (ADPKD).
Kistler, Andreas D. +10 more
core
Heterogeneous Cardiovascular Profiles in CKD: ADPKD Versus non-ADPKD
Au, Eric H.K., Gupta, Aditi
openaire +2 more sources

